Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Counseling and NRT for African American Non-Daily Smokers
NCT02244918Phase 4Completed
- Sponsor
- University of Kansas Medical Center
- Start
- May 2015
- Primary completion
- Nov 2017
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nicotine patch in Tobacco Use Disorder (TUD), sponsored by University of Kansas Medical Center. Primary endpoint: Smoking Abstinence at 12 weeks. Started May 2015; status: completed.
02
Drugs
nicotine patch
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02244918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02244918.